These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 8059228)

  • 41. Tissue factor pathway inhibitor in infants and children.
    Weissbach G; Harenberg J; Wendisch J; Pargac N; Thomas K
    Thromb Res; 1994 Mar; 73(6):441-6. PubMed ID: 8073396
    [No Abstract]   [Full Text] [Related]  

  • 42. [Tissue factor pathway inhibitor: biochemistry, molecular biology, physiology and physiopathology].
    Witt I
    Hamostaseologie; 2002 May; 22(2):30-5. PubMed ID: 12193974
    [No Abstract]   [Full Text] [Related]  

  • 43. Tifacogin, recombinant tissue factor pathway inhibitor.
    Matyal R; Mahmood F; Park KW
    Int Anesthesiol Clin; 2005; 43(2):135-44. PubMed ID: 15795568
    [No Abstract]   [Full Text] [Related]  

  • 44. Requirements of chemical structure of hormonal activity of lipopeptidyl factors inducing sexual differentiation in vegetative cells of heterobasidiomycetous yeasts.
    Tsuchiya E; Fukui S; Kamiya Y; Sakagami Y; Fujino M
    Biochem Biophys Res Commun; 1978 Nov; 85(1):459-63. PubMed ID: 743289
    [No Abstract]   [Full Text] [Related]  

  • 45. The hemostatic system and angiogenesis in malignancy.
    Wojtukiewicz MZ; Sierko E; Klement P; Rak J
    Neoplasia; 2001; 3(5):371-84. PubMed ID: 11687948
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Loss of heparin-releasable tissue factor pathway inhibitor in patients undergoing PTCA.
    Anderson S; Cohen AT; Melissari E; Scully MS; Kakkar VV
    Thromb Haemost; 1995 Feb; 73(2):328-9. PubMed ID: 7792754
    [No Abstract]   [Full Text] [Related]  

  • 47. Tissue factor pathway inhibitor.
    Novotny WF
    Semin Thromb Hemost; 1994; 20(1):101-8. PubMed ID: 8059228
    [No Abstract]   [Full Text] [Related]  

  • 48. Tissue factor pathway inhibitor: a potent inhibitor of in-vitro coagulation and in-vivo thrombus formation.
    Lindahl AK
    Curr Opin Lipidol; 1994 Dec; 5(6):434-9. PubMed ID: 7712048
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The role of tissue factor and its inhibitor in hemostasis].
    Naumnik B; Małyszko J; Myśliwiec M
    Przegl Lek; 1998; 55(2):68-73. PubMed ID: 9695646
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tissue factor pathway inhibitor and antithrombin trial results.
    LaRosa SP; Opal SM
    Crit Care Clin; 2005 Jul; 21(3):433-48. PubMed ID: 15992666
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tissue factor pathway inhibitor.
    Camici M; Sagripanti A
    Minerva Med; 1999; 90(1-2):25-32. PubMed ID: 10388460
    [TBL] [Abstract][Full Text] [Related]  

  • 52.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 53.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.